Search NASA⌕ Search

Engineering topics

Weston, Brian

Publications and source records attributed to Weston, Brian.

Preconditioning a Newton-Krylov solver for all-speed melt pool flow physics

n this paper, we introduce a multigrid block-based preconditioner for solving linear systems arising from a Discontinuous Galerkin discretization of the all-speed Navier-Stokes equations with phase change. The equations are discretized in conservative form with a reconstructed Discontinuous Galerkin (rDG) method and integrated with fully-implicit time discretization schemes. To robustly converge the numerically stiff systems, we use the Newton-Krylov framework with a primitive-variable formulation (pressure, velocity, and temperature), which is better conditioned than the conservative-variable form at low-Mach number. In the limit of large acoustic CFL number and viscous Fourier number, there is a strong coupling between the velocity-pressure system and the linear systems become non-diagonally dominant. To effectively solve these ill-conditioned systems, an approximate block factorization preconditioner is developed, which uses the Schur complement to reduce a 3 x 3 block system into a sequence of two 2 x 2 block systems: velocity-pressure,v P , and velocity-temperature, v T . We compare the performance of the v P -v T Schur complement preconditioner to classic preconditioning strategies: monolithic algebraic multigrid (AMG), element-block SOR, and primitive variable block Gauss-Seidel. The performance of the preconditioned solver is investigated in the limit of large CFL and Fourier numbers for low-Mach lid-driven cavity flow, Rayleigh-Bénard melt convection, compressible internally heated convection, and 3D laser-induced melt pool flow. Here, numerical results demonstrate that the v P -v T Schur complement preconditioned solver scales well both algorithmically and in parallel, and is robust for highly ill-conditioned systems, for all tested rDG discretization schemes (up to 4th-order).

97 MATHEMATICS AND COMPUTING↗

First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma

Background: Preoperative chemotherapy provides early treatment of micro-metastases and guaranteed delivery of all components of multimodality therapy for localized pancreatic ductal adenocarcinoma (PDAC). For locally advanced (LA) PDAC, induction chemotherapy is the standard of care. This study evaluated the use of gemcitabine and nab-paclitaxel (Gem/nab-P) as first-line therapy for localized PDAC. Methods: Clinicopathologic features, treatment, and outcomes were evaluated for 99 patients with localized PDAC. The patients were staged using previously published criteria as follows: potentially resectable (PR), borderline type A (BR-A) (anatomy amenable to vascular resection), BR-B (biology suspicious for metastatic disease including high CA19-9), BR–C (comorbidities requiring medical optimization), and LA. Results: The 99 patients (PR/BR/LA: 45/14/40) were treated with Gem/nab-P. Clinical staging showed that 20 patients had PR or BR-A disease, whereas 39 patients had BR-B or BR-C disease. The BR-B+C cases included one or more of the following: age of 80 years or older (13%), Eastern Cooperative Oncology Group performance status (ECOG PS) of 2 or more (13%), moderate to severe comorbidities (55%), CA19-9 of 1000 or higher (28%), and suspicion for metastases (21%). The majority of the patients received biweekly Gem/nab-P dosing, which was well tolerated. Pancreatectomy was performed for 12 (60%) of 20 patients with PR+BR-A, 2 (5%) of 39 patients with BR-B+C, and 1 (3%) of 40 patients with LA disease. During a median follow-up period of 26 months, the median overall survival (OS) period was 18 months (95% confidence interval [CI], 15.6–20.5 months) for all the patients, 17 months (95% CI, 14.6–19.5 months) for the unresected patients, and not reached for the resected patients (p = 0.028 for resected vs unresected patients). Conclusions: A significant number of patients with radiographically resectable PDAC albeit aggressive biology (BR-B), medically inoperable conditions (BR-C), or both received biweekly first-line Gem/nab-P. The resection rates were lower for the BR-B/BR-C patients than for the PR/BR-A patients (hazard ratio [HR], 0.43; 95% CI, 0.19–1.00; p = 0.05).

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Scale Dependence of Multiplier Distributions for Particle Concentration, Enstrophy, and Dissipation in the Inertial Range of Homogeneous Turbulence

Turbulent flows preferentially concentrate inertial particles depending on their stopping time or Stokes number, which can lead to significant spatial variations in the particle concentration. Cascade models are one way to describe this process in statistical terms. Here, we use a direct numerical simulation (DNS) dataset of homogeneous, isotropic turbulence to determine probability distribution functions (PDFs) for cascade multipliers, which determine the ratio by which a property is partitioned into subvolumes as an eddy is envisioned to decay into smaller eddies. We present a technique for correcting effects of small particle numbers in the statistics. We determine multiplier PDFs for particle number, flow dissipation, and enstrophy, all of which are shown to be scale dependent. However, the particle multiplier PDFs collapse when scaled with an appropriately defined local Stokes number. As anticipated from earlier works, dissipation and enstrophy multiplier PDFs reach an asymptote for sufficiently small spatial scales. From the DNS measurements, we derive a cascade model that is used it to make predictions for the radial distribution function (RDF) for arbitrarily high Reynolds numbers, Re, finding good agreement with the asymptotic, infinite Re inertial range theory of Zaichik and Alipchenkov [New J. Phys. 11, 103018 (2009)]. We discuss implications of these results for the statistical modeling of the turbulent clustering process in the inertial range for high Reynolds numbers inaccessible to numerical simulations.

turbulent flows↗